Ara
Toplam kayıt 117, listelenen: 91-100
Rapid Evolution and Spread of Carbapenemases Among Enterobacteriaceae in Europe
(Elsevier Sci Ltd, 2012)
Plasmid-acquired carbapenemases in Enterobacteriaceae, which were first discovered in Europe in the 1990s, are now increasingly being identified at an alarming rate. Although their hydrolysis spectrum may vary, they hydrolyse ...
Sulbactam-Containing Beta-Lactamase Inhibitor Combinations
(Blackwell Publishing, 2008)
Sulbactam irreversibly inhibits the hydrolytic activity of beta-lactamases. This compound is commercially available in combination with either ampicillin or cefoperazone. In each instance, the activity of the partner ...
Variability In Protein Binding Of Teicoplanin And Achievement Of Therapeutic Drug Monitoring Targets In Critically Ill Patients: Lessons From The Dali Study
(Elsevier, 2014)
The aims of this study were to describe the variability in protein binding of teicoplanin in critically ill patients as well as the number of patients achieving therapeutic target concentrations. This report is part of the ...
Characterization Of Beta-Lactamase Gene Bla(Per-2,) Which Encodes An Extended-Spectrum Class A Beta-Lactamase
(Amer Soc Microbiology, 1996)
Plasmidic extended-spectrum beta-lactamases of Ambler class A are mostly inactive against ceftibuten. Salmonella typhimurium JMC isolated in Argentina harbors a bla gene located on a plasmid (pMVP-5) which confers transferable ...
Controlling The Spread Of Carbapenemase-Producing Gram-Negatives: Therapeutic Approach And Infection Control
(Elsevier Sci Ltd, 2010)
Although the rapid spread of carbapenemase-producing Gram-negatives (CPGNs) is providing the scientific community with a great deal of information about the molecular epidemiology of these enzymes and their genetic background, ...
Ertapenem For The Treatment Of Bloodstream Infections Due To Esbl-Producing Enterobacteriaceae: A Multinational Pre-Registered Cohort Study
(Oxford Univ Press, 2016)
Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other ...
Escmid* Guideline For The Diagnosis And Management Of Candida Diseases 2012: Adults With Haematological Malignancies And After Haematopoietic Stem Cell Transplantation (Hct)
(Elsevier Sci Ltd, 2012)
Clin Microbiol Infect 2012; 18 (Suppl. 7): 5367 Abstract Fungal diseases still play a major role in morbidity and mortality in patients with haematological malignancies, including those undergoing haematopoietic stem cell ...
Escmid* Guideline For The Diagnosis And Management Of Candida Diseases 2012: Developing European Guidelines In Clinical Microbiology And Infectious Diseases
(Elsevier Sci Ltd, 2012)
Clin Microbiol Infect 2012; 18 (Suppl. 7): 18 Abstract The process to develop a guideline in a European setting remains a challenge. The ESCMID Fungal Infection Study Group (EFISG) successfully achieved this endeavour. ...
Escmid* Guideline For The Diagnosis And Management Of Candida Diseases 2012: Non-Neutropenic Adult Patients
(Elsevier Sci Ltd, 2012)
Clin Microbiol Infect 2012; 18 (Suppl. 7): 1937 Abstract This part of the EFISG guidelines focuses on non-neutropenic adult patients. Only a few of the numerous recommendations can be summarized in the abstract. Prophylactic ...
Escmid* Guideline For The Diagnosis And Management Of Candida Diseases 2012: Patients With Hiv Infection Or Aids
(Elsevier Sci Ltd, 2012)
Clin Microbiol Infect 2012; 18 (Suppl. 7): 6877 Abstract Mucosal candidiasis is frequent in immunocompromised HIV-infected highly active antiretroviral (HAART) naive patients or those who have failed therapy. Mucosal ...